Lv1
20 积分 2025-09-09 加入
A Second-Generation Route to the Cereblon Fragment of ARV-471, Vepdegestrant
2个月前
已完结
Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond
3个月前
已完结
The PROTACtable genome
3个月前
已完结
Recent Advances in PROTACs for Drug Targeted Protein Research
3个月前
已完结
Chemistries of bifunctional PROTAC degraders
3个月前
已完结
Development of a Commercial Manufacturing Process for Vepdegestrant, an Orally Bioavailable PROTAC Estrogen Receptor Degrader for the Treatment of Breast Cancer
4个月前
已完结
Crystal structure, thermal crystal form transformation, desolvation process and desolvation kinetics of two novel solvates of ciclesonide
4个月前
已完结
Prevalence of Impurity Retention Mechanisms in Pharmaceutical Crystallizations
5个月前
已完结
A Structured Approach To Cope with Impurities during Industrial Crystallization Development
5个月前
已完结
Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals
5个月前
已完结
皖公网安备34019202002308
